Noninvasive Radiofrequency TruSculpt
ProcedureHeating subcutaneous fat up to 45℃ continuously at least 3 minutes without surface damage and induces adipocytes apoptosis.
Other names: TruSculpt
NCT Number: NCT02512822
To evaluate the efficacy of novel noninvasive RF technology for reduction of submental fat.
Looking for future studies?
Notify Me20 year–75 year
All sexes
Interventional
Not applicable
Recently, Novel radiofrequency (RF) technology was introduced as a promising tool for non-invasive body and face contouring, which can heats subcutaneous fat up to 45℃ continuously without surface damage and induces adipocytes apoptosis.
Subjects with an excessive subcutaneous fat on the submental area received twice treatments at 1-month intervals. Clinical outcomes including the thickness of the submental fat (measured by ultrasound) and the submental circumference (measured by a tape measure), and clinical photographs were obtained at baseline, and 1-month and 6-month after last treatment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Heating subcutaneous fat up to 45℃ continuously at least 3 minutes without surface damage and induces adipocytes apoptosis.
Other names: TruSculpt
Time frame: 6 months
thickness of the submental fat measured by ultrasound
Time frame: 6 months
thickness of the submental fat measured by a tape measure
Time frame: 6 months
assessment for improvement by participants
Time frame: 6 months
assessment for satisfaction by participants
Kangbuk Samsung Hospital
Other
Acronym: UNIRFFC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05234736
Subcutaneous Fat
Austin, Texas, United States
View Trial DetailsNCT06005441
Subcutaneous Fat
Omaha, Nebraska, United States
View Trial DetailsNCT04575467
Subcutaneous Fat
Melbourne, Victoria, Australia
View Trial DetailsNCT05736107
Subcutaneous Fat
Pflugerville, Texas, United States
View Trial Details